1,2-Dichloroethane → (2r)-3-[(4-{[1h-Benzimidazol-2-yl(4-tert-butylcyclohexyl)amino]methyl}benzoyl)-amino]-2-hydroxypropanoic acid

HRID 229987ノート

反応式

HRID 229987 の反応式
[NH:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[N:10]([CH2:21][C:22]1[CH:30]=[CH:29][C:25]([C:26](O)=[O:27])=[CH:24][CH:23]=1)[CH:11]1[CH2:16][CH2:15][CH:14]([C:17]([CH3:20])([CH3:19])[CH3:18])[CH2:13][CH2:12]1.C[O:32][C:33](=[O:38])[CH:34]([OH:37])[CH2:35][NH2:36].C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl.CCN(C(C)C)C(C)C.[Li+].[OH-].C(O)(C(F)(F)F)=O>CN(C=O)C.O>[NH:1]1[C:5]2[CH:6]=[CH:7][CH:8]=[CH:9][C:4]=2[N:3]=[C:2]1[N:10]([CH2:21][C:22]1[CH:30]=[CH:29][C:25]([C:26]([NH:36][CH2:35][C@@H:34]([OH:37])[C:33]([OH:32])=[O:38])=[O:27])=[CH:24][CH:23]=1)[CH:11]1[CH2:16][CH2:15][CH:14]([C:17]([CH3:20])([CH3:18])[CH3:19])[CH2:13][CH2:12]1

参加物

10

反応物 7

HCID 111,2-DichloroethaneHCID 3939Lithium HydroxideHCID 6422Trifluoroacetic acidHCID 757711-HydroxybenzotriazoleHCID 81531DiisopropylethylamineHCID 11105589Methyl 3-amino-2-hydroxypropanoateHCID 688356554-{[1h-Benzimidazol-2-yl(4-tert-butylcyclohexyl)amino]methyl}benzoic acid

生成物 1

HCID 57758798(2r)-3-[(4-{[1h-Benzimidazol-2-yl(4-tert-butylcyclohexyl)amino]methyl}benzoyl)-amino]-2-hydroxypropanoic acid

試薬・触媒・溶媒 2

HCID 962Water溶媒HCID 6228Dimethylformamide溶媒

実験手順

To a solution of the title compound of Example 1 Step D (0.04 mmol, 16 mg), the hydrochloride salt of 2-hydroxy β-alanine methyl ester (0.06 mmol, 9 mg), HOBt (0.1 mmol, 15 mg), and EDC (0.12 mmol, 23 mg) in 0.4 mL of DMF was added DIEA (0.2 mmol, 35 μL). After 3 h the reaction was partitioned into EtOAc/brine. The organic phase was dried with MgSO4 and concentrated under reduced pressure. The residue was taken up in 1 mL of dioxane and a solution of LiOH (1 mmol, 24 mg) in 0.5 mL of H2O was added. The reaction was stirred at ambient temperature overnight, acidified with TFA and the product was purified by reverse-phase chromatography (Condition A) and lyophilized, affording the title compound as a white solid. MS (ESI): m/z 493 (M+H). HPLC A: 1.73 min.

後処理

  1. customAfter 3 h the reaction was partitioned into EtOAc/brine
  2. dry with materialThe organic phase was dried with MgSO4
  3. concentrationconcentrated under reduced pressure
  4. customthe product was purified by reverse-phase chromatography (Condition A) and

出典と根拠

ORDレコード
ord-d464e379e9b44668aa1fbe1e62a81124
出典データセット
uspto-grants-2009_07
特許番号
US07563815B2

反応ノート

読み込み中…